Investor Relations

News Releases

News Releases

Aug 14, 2020
PPD, Inc. (Nasdaq:PPD) today announced that two PPD senior leaders have been named to the 2020 PharmaVOICE 100 list of the most inspiring people in the life sciences industry: Karen Kaucic, M.D., chief medical officer of PPD and president of Evidera, and Rhonda Henry, vice president of patient-centered trials.
Aug 03, 2020
PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, today announced it has signed a new three-year agreement with Pfizer Inc. to provide drug development services to advance Pfizer’s portfolio.
May 21, 2020
PPD, Inc. (Nasdaq:PPD) (the “Company”), a leading global contract research organization, today announced that Jaguar Holding Company II (“Jaguar”) and PPD Development, L.P. (“PPD Development” and, together with Jaguar, the “Co-Issuers”), both indirect wholly owned subsidiaries of the Company, successfully upsized and finalized the terms of the Co-Issuers’ offering of $500 million aggregate principal amount of 4.625% senior notes due 2025 and $700 million aggregate principal amount 5.000% senior notes due 2028 (collectively, the “Notes”).
May 21, 2020
PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, today announced that it intends to offer $700 million in aggregate principal amount of senior notes, subject to market and other conditions.
May 06, 2020
PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, today reported its financial results for the first quarter ended March 31, 2020.
Displaying 11 - 20 of 33